Companies / enGene Therapeutics Inc. / Activity
Activity — enGene Therapeutics Inc.
20 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | MAI Capital Management 13F manager | Exit | Common stock | $-7.0K | -776 -100.00% | 0 | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common stock | $-16.6K | -2K -1.51% | 159,069 0.24% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Add | Common stock | $18.0K | +3K +33.23% | 10,545 0.02% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $66.6K | +10K +33.72% | 38,802 0.06% of shares | low |
| Q1 2026 as of | DAFNA Capital Management LLC 13F manager | Add | Common stock | $161.5K | +24K +14.49% | 187,353 0.28% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common Stock | $198.1K | +114K | 114,493 0.17% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common stock | $200.4K | +29K +82.01% | 65,301 0.10% of shares | low |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Trim | Common stock | $-283.1K | -42K -0.71% | 5,827,506 8.70% of shares | low |
| Q2 2026 as of | Privium Fund Management B.V. 13F manager | New | Common Stock | $294.1K | +170K | 170,000 0.25% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Add | Common stock | $329.5K | +190K +392.01% | 239,035 0.36% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common Stock | $413.5K | +239K | 239,035 0.36% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common stock | $921.5K | +135K +651.13% | 156,100 0.23% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common Stock | $2.34M | +344K | 343,928 0.51% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Exit | Common stock | $-3.11M | -344K -100.00% | 0 | low |
| Q2 2026 as of | Privium Fund Management B.V. 13F manager | Exit | Common stock | $-3.18M | -352K -100.00% | 0 | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-3.68M | -540K -36.00% | 959,681 1.43% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Exit | Common stock | $-4.42M | -647K -100.00% | 0 | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $7.82M | +1.1M | 1,148,997 1.72% of shares | medium |
| Q2 2026 as of | BML Capital Management, LLC 13F manager | New | Common Stock | $11.54M | +6.7M | 6,669,908 9.96% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Exit | Common stock | $-17.11M | -1.9M -100.00% | 0 | medium |